No Data
No Data
Form 144 | Enliven Therapeutics(ELVN.US) Director Proposes to Sell 121.77K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Enliven Therapeutics(ELVN.US)$ Director The Biotech Growth Trust PLC intends to sell 5,500 shares of its common stock on May 16, with a total market value of approxima
Form 144 | Enliven Therapeutics(ELVN.US) Director Proposes to Sell 22.14 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Enliven Therapeutics(ELVN.US)$ Director OrbiMed Private Investments VII, LP intends to sell 1 million shares of its common stock on May 16, with a total market value o
Form 144 | Enliven Therapeutics(ELVN.US) Director Proposes to Sell 737.26K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Enliven Therapeutics(ELVN.US)$ Director OrbiMed Genesis Master Fund, L.P. intends to sell 33,300 shares of its common stock on May 16, with a total market value of app
Enliven Therapeutics(ELVN.US) Officer Sells US$27,675 in Common Stock
$Enliven Therapeutics(ELVN.US)$ Officer Patel Anish sold 1,107 shares of common stock on May 14, 2024 at an average price of $25 for a total value of $27,675.Source: Announcement What is statement of
Enliven Therapeutics: A Strong Buy on Market Dynamics and Scemblix's Breakthrough Therapy Designation Impact
Analysts Offer Insights on Healthcare Companies: Iridex (IRIX), Nyxoah (NYXH) and Enliven Therapeutics (ELVN)
No Data